Connect with us

Health

COVID Vaccine Updates: Novavax nears end of US trial, could submit to FDA in May – WABC-TV

We’re another step closer to getting another vaccine on the market.

Published

on

Article feature image

NEW YORK (WABC) — We’re another step closer to getting another vaccine on the market.Novavax is expected to finish its trial in May, and at that time could submit to the FDA for emergency use authorization.
That’s after announcing the company’s UK trial showed 100% protection against hospitalizations and death.The trial data also showed it was 96% effective in symptomatic disease caused by the original virus, and 86% effective against the variant that originated in the UK.
What to know about coronavirus:

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending